TrueDialog Enhances Enterprise Security and User Experience with Single Sign-On (SSO) 
Benevity Releases First Enterprise Impact Platform to Solve CSR and Social Impact’s Biggest Challenges LIDDS files patent application for method to treat brain cancer with intratumoral depot injections
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid®…
Segra Enters Agreement Making BioAgronomics Group’s Premium Cannabis Cultivar Portfolio Available to Licensed Producers Across Canada and Select International Markets
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Segra International Corp., an AgTech firm…
AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer
Prof. Casper van Eijck, surgeon and a global leading expert in pancreatic cancer Prof. Casper…
Lixte Biotechnology to Present Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual H.C. Wainwright Global Life Sciences Conference
LB-100 is Currently in Clinical Studies for Four Cancer Targets: Phase 1b/2 for Myelodysplastic (MDS)…
22nd Century Group Provides Business Update Letter from CEO
Global Commercial Opportunities in Approximately +$800 Billion Markets Across Tobacco and Hemp/Cannabis WILLIAMSVILLE, N.Y., Feb….
Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy
Phase 1b trial demonstrates that the company’s lead precision medicine asset is safe and well…
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
DURHAM, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company…
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Complete Vaccine™ Development Program
Ii-Key-SARS-CoV-2 vaccine generates vaccine-specific antibodies and T cell responses in a transgenic mouse model The…
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
Strategic Partnership Optimizes Integration for EHR Data and Delivers Remote Source Data Review MORRISVILLE, N.C….
Medexus Schedules Third Quarter Fiscal 2021 Conference Call
TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the…
Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference
BOSTON, Feb. 24, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Longeveron Announces Successful Completion of Phase 1 Clinical Study of Lomecel-B Intramyocardial Injection in Hypoplastic Left Heart Syndrome Patients
Intramyocardial injection of Lomecel-B well-tolerated, with no major cardiac events, and no serious adverse events…
Kane Biotech Announces New Chairman
WINNIPEG, Manitoba, Feb. 24, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March
NEWTON, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage…
89bio to Present at the 42nd Annual Raymond James Institutional Investors Conference
SAN FRANCISCO, Feb. 24, 2021 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference
CHARLESTON, S.C., Feb. 24, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
BioCorRx Appoints Finance Veteran Joseph J. Galligan to the Board of Directors
ANAHEIM, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a…
Motus GI Announces U.S. Patent for the Pure-Vu® System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy
FORT LAUDERDALE, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Oncternal Therapeutics to Participate in March Investor Conferences
– H.C. Wainwright: Global Life Sciences Conference –March 9th – 10th – Oppenheimer 31st Annual…
Recce Pharmaceuticals Applies for Dual Listing on FSE (Frankfurt Stock Exchange)
Highlights: Broadens institutional and retail investor base across EU and enables access to additional capital markets…